Opioid Maker Insys Pleads Guilty, Pays $225M In Fines, False Claims Settlement

Mealey's (June 6, 2019, 11:45 AM EDT) -- BOSTON — A subsidiary of opioid manufacturer Insys Therapeutics Inc. on June 5 pleaded guilty to mail fraud and the parent company agreed to pay $225 million in fines, forfeiture and...
To view the full article, register now.